We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
HLK Biotech Holding Group Inc (CE) | USOTC:AMHD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 00:00:00 |
The Subsidiary's mandate is to buy undervalued properties in strategic locations and to perform eco-friendly market renovations that significantly increase the resale value of the properties. These newly upgraded residences will be environmentally responsible and resource-efficient that will make them attractive for buyers.
Since its inception last month, Amelot Properties has purchased four residential properties. One was put on the market and re-sold with minimum upgrades due to market demand. The other two properties were sold within two days after the completion of the renovations. The fourth property was purchased yesterday. The renovation plan is in place and the crew will begin working on it next week and is expected to be completed by the end of the month to be ready for marketing.
Upon sale and closing of these four properties, the Company expects to book a net profit in excess of $75,000. Three additional properties have also been identified for purchase and the offers have been submitted this week.
"We are targeting properties that require no major structural work, and can have a 10 day or less turnaround, thus allowing each crew to complete three properties per month. We have assembled a multi-talented crew with years of combined experience. All renovations will include the upgrading of major appliances to more energy efficient models and environmentally friendly models. In some of the properties, we are planning to utilize advanced environmentally conservation measures, such as solar technology," commented Fred Guarnieri, President and CEO.
On January 12, 2010, Mr. Guarnieri completed the purchase of an additional 75 million shares of the Company's common stock, bringing his total to 1,076,275,000. The Company currently has 4,624,573,155 shares outstanding.
Over the next few weeks, the Company will be issuing further updates on its other subsidiaries.
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com), a publicly traded company, is a diversified holding company that has identified Biodiesel as a multi-billion emerging Biofuel market. Amelot plans to have a significant market share in growing low cost feedstocks to supply the growing demand for biodiesel, to reduce energy dependency of fossil fuels, to help reduce the U.S. dependency on foreign oil supplies and reduce the impact of energy on our environment.
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
Contact: Amelot Holdings, Inc. 1-(646)-926-3568 support@amelotholdings.com http://www.amelotholdings.com
1 Year HLK Biotech (CE) Chart |
1 Month HLK Biotech (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions